We recently published an article titled Why These 10 Stocks Soared Today. In this article, we are going to take a look at ...

Medical pioneers Hims & Hers Health (HIMS) and Novo Nordisk (NVO) are making headlines this week after announcing a partnership to expand obesity care in the telehealth space.

Novo Nordisk said that it will begin offering its popular weight loss drug Wegovy through telehealth companies Hims & Hers, Ro and LifeMD to expand patient access, now that the medication is no longer ...

Wegovy, the popular weight-loss drug from Novo Nordisk, will be available through several leading telehealth providers, ...

Novo Nordisk is expanding access to its GLP-1 drug Wegovy via telehealth, partnering with Hims and Hers, Ro, and LifeMD.

Gilead held dinners to promote its HIV medications at expensive restaurants that federal authorities claim were “wholly inappropriate” venues, Stat reported. Gilead said it settled to avoid the cost ...

After going after the companies making compounded versions of their drugs, GLP-1 makers are now going into business with the online telehealth sites that were previously selling the copycats.

Novo Nordisk has sought strength in numbers in the battle for telehealth obesity drug sales in the US, enlisting the aid of ...

Hims & Hers Health (HIMS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings ...

Hims & Hers Health (NYSE: HIMS) stock surged 23% on Tuesday, April 29, after Novo Nordisk announced plans to offer popular ...

Drugmaker Novo Nordisk announced Tuesday that Wegovy will be available through telehealth providers. The providers -- Hims & ...

Novo Nordisk A/S said it would sell its popular weight-loss drug Wegovy for a steeply reduced price on several telehealth ...